Healthy sugars, breakthrough semaglutide and the popularity of obesity drugs

The Karolinska Institute in Sweden conducted a study on the impact of fat cell size and number on long-term changes in human body weight. The experiment found that people with larger fat cells tended to lose weight, while those with smaller fat cells were more likely to gain weight. However, individuals with smaller fat cells were also less likely to develop weight-related diseases.

Medications like Ozempic and Mounjaro lower blood sugar levels by mimicking the hormone that stimulates insulin production. This reduces the reliance on insulin for people with type 2 diabetes. Meanwhile research from the University College London revealed that patients taking semaglutide, found in Wegovy and Ozempic, had a 20% lower risk of heart attack, stroke, and death from cardiovascular diseases. Semaglutide was also noted for its positive effects on the cardiovascular system and weight loss.

A study among physically fit male teenagers, particularly Swedish army conscripts, showed that the risk of severe coronary artery narrowing almost 40 years later was 33% lower compared to their less fit peers. Additionally, experts from the University of Groningen highlighted the importance of the source of sugar in childhood obesity, stating that sugar from fruit and unsweetened liquid dairy products, such as milk, is safer than other sources.